Assessment of the Risk-Benefit Ratio for Antiarrhythmic Drug Use
- 1 November 1988
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 36 (5) , 616-632
- https://doi.org/10.2165/00003495-198836050-00005
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Aplastic Anemia Due to TocainideNew England Journal of Medicine, 1986
- Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy.Circulation, 1985
- Intramuscular Lidocaine for Prevention of Lethal Arrhythmias in the Prehospitalization Phase of Acute Myocardial InfarctionNew England Journal of Medicine, 1985
- Sudden unexpected death in patients with congestive heart failure: a second frontier.Circulation, 1985
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Long-Term Follow-up of Asymptomatic Healthy Subjects with Frequent and Complex Ventricular EctopyNew England Journal of Medicine, 1985
- Risk Stratification and Survival after Myocardial InfarctionNew England Journal of Medicine, 1983
- A new method for evaluating antiarrhythmic drug efficacy.Circulation, 1980